Abstract
BackgroundImmunotherapies are becoming front-line treatments for many advanced cancers, and combinations of two or more therapies are beginning to be investigated. Based on their individual antitumor capabilities, we sought to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have